In the late trading session on Thursday, April 7, 2022, the immune-oncology therapeutics developer, Exicure Inc. (XCUR) witnessed an upsurge. XCUR was among the penny
On March 01, 2022, shares of Exicure Inc. (XCUR) stock continued to rise in the after hours. The company reported no official announcement or SEC
On January 25, Exicure Inc. (XCUR) stock soared in the after-hours to gain a huge 28.24%. The stock seems to be gaining on external factors
Mereo BioPharma Group plc (MREO) stock plunged -7.78% to $3.32 in the pre-market trading after declaring collaboration and license agreement with Ultragenyx Pharmaceutical Inc. (RARE),
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.